Orexigen Therapeutics Inc (OREX)

The 30 most obese countries in the world in 2018 represent a huge (pun intended) market opportunity for weight loss drugmakers.

The worries about the election and the ongoing uncertainty about the path of interest-rate increases have been keeping investors on the sidelines.

Although a great movie, The Wolf of Wall Street left many people thinking penny stocks are somewhat 'untouchable'.

No doubt, penny stocks are for investors with a greater than average risk appetite, but considering their inexpensiveness and the possibility of towering returns, if any of these companies make it big...

Cheyne Capital is one of the few non-U.S firms that we track in our database.

Seth Klarman’s Baupost Group has initiated a new passive stake in Orexigen Therapeutics Inc. (NASDAQ:OREX), a new filing the U.S. Securities and Exchange Commission showed.

Investing in the healthcare sector can be tricky, especially if you're looking for high returns and want to invest in clinical-stage companies, which represent an above-average risk.

In the first hours of trading, the markets showed slight signs of improvement, impacted by positive jobless claims data.

Jim Tananbaum’s Foresite Capital has filed its latest 13F with the Securities and Exchange Commission for the reporting period of March 31, disclosing the long positions held in its equity portfolio...